X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (791) 791
index medicus (731) 731
humans (579) 579
glucose (432) 432
male (388) 388
glucose - metabolism (360) 360
physiology (289) 289
rats (275) 275
sodium-glucose transporter 1 - metabolism (273) 273
diabetes (258) 258
sodium-glucose transporter 1 (258) 258
sodium-glucose transporter 2 - antagonists & inhibitors (256) 256
dextrose (244) 244
female (220) 220
diabetes mellitus, type 2 - drug therapy (208) 208
mice (207) 207
biochemistry & molecular biology (183) 183
endocrinology & metabolism (183) 183
sodium (178) 178
monosaccharide transport proteins - metabolism (177) 177
sodium-glucose transporter 2 - metabolism (174) 174
expression (172) 172
type 2 diabetes (169) 169
sodium-glucose transporter 1 - genetics (156) 156
hypoglycemic agents - therapeutic use (151) 151
membrane glycoproteins - metabolism (148) 148
sglt1 (145) 145
glucose metabolism (143) 143
dapagliflozin (139) 139
cell biology (135) 135
diabetes mellitus (133) 133
insulin (126) 126
sodium - metabolism (121) 121
hyperglycemia (117) 117
kidney - metabolism (111) 111
glucosides - therapeutic use (110) 110
blood glucose - metabolism (108) 108
monosaccharide transport proteins - genetics (108) 108
pharmacology & pharmacy (108) 108
hypoglycemic agents - pharmacology (107) 107
research (106) 106
double-blind (105) 105
transport (105) 105
na+/glucose cotransporter (103) 103
glucosides - pharmacology (102) 102
physiological aspects (101) 101
absorption (99) 99
rats, sprague-dawley (98) 98
rodents (97) 97
kinetics (95) 95
gene expression (94) 94
analysis (91) 91
kidney (89) 89
rna, messenger - metabolism (89) 89
diabetes mellitus, type 2 - metabolism (88) 88
metabolism (88) 88
biological transport (86) 86
cells (85) 85
phlorhizin - pharmacology (85) 85
membrane glycoproteins - genetics (84) 84
rats, wistar (82) 82
canagliflozin (81) 81
medicine & public health (81) 81
empagliflozin (79) 79
sglt2 inhibitor (79) 79
type-2 diabetes-mellitus (78) 78
benzhydryl compounds - therapeutic use (77) 77
jejunum - metabolism (77) 77
xenopus laevis (77) 77
intestinal mucosa - metabolism (76) 76
middle aged (74) 74
sodium-glucose transporter 1 - antagonists & inhibitors (74) 74
transporter (74) 74
glycemic control (73) 73
brush-border membrane (72) 72
hypoglycemic agents (72) 72
proteins (72) 72
sglt2 (71) 71
urology & nephrology (71) 71
microvilli - metabolism (70) 70
treatment outcome (70) 70
article (69) 69
rabbits (68) 68
sodium-glucose transport proteins - metabolism (68) 68
glucose transporter (67) 67
blood glucose - drug effects (66) 66
glucose transporter type 2 - metabolism (66) 66
internal medicine (66) 66
intestine, small - metabolism (66) 66
kidney - drug effects (66) 66
mice, inbred c57bl (66) 66
health aspects (64) 64
intestine (63) 63
abridged index medicus (62) 62
risk factors (62) 62
sglt2 inhibitors (62) 62
sodium-glucose transporter 2 - genetics (61) 61
type 2 diabetes mellitus (61) 61
digestive, oral, and skin physiology (59) 59
kidney tubules, proximal - metabolism (59) 59
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1185) 1185
Japanese (11) 11
Chinese (4) 4
Russian (3) 3
Spanish (3) 3
French (1) 1
German (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Diabetologia, ISSN 0012-186X, 10/2018, Volume 61, Issue 10, pp. 2087 - 2097
The concentration of glucose in plasma is held within narrow limits (4–10 mmol/l), primarily to ensure fuel supply to the brain. Kidneys play a role in glucose... 
GLUTs | Human Physiology | SGLTs | Metabolic Diseases | Internal Medicine | Glucose | Review | Type 2 diabetes mellitus | Gliflozins | Kidney | Proximal tubule | Phlorizin | Inhibitors | Medicine & Public Health | SODIUM | FANCONI-BICKEL-SYNDROME | LOW-AFFINITY | NA+/GLUCOSE COTRANSPORTER SGLT2 | TRANSPORT | THERAPEUTIC TARGET | ENDOCRINOLOGY & METABOLISM | PHLORHIZIN | EXPRESSION | BINDING | Glucose Transporter Type 2 - genetics | Humans | Sodium-Glucose Transporter 2 Inhibitors - pharmacology | Homeostasis | Diabetes Mellitus, Type 2 - metabolism | Sodium-Glucose Transporter 1 - physiology | Sodium-Glucose Transporter 1 - genetics | Glycosuria - metabolism | Hypoglycemic Agents - pharmacology | Mice, Knockout | Sodium-Glucose Transporter 2 - physiology | Kidney - metabolism | Animals | Glucose Transporter Type 2 - physiology | Drug Design | HEK293 Cells | Kidney Tubules, Proximal - metabolism | Glucose - metabolism | Mice | Blood Glucose - metabolism | Kidney Tubules - metabolism | Phlorhizin - pharmacology | Sodium-Glucose Transporter 2 - genetics | Type 2 diabetes | Medical colleges | Analysis | Physiological aspects | Hypoglycemic agents | Dextrose | Membrane proteins | Glucose transporter | Urine | Excretion | Intravenous administration | Renal function | Kidneys | Diabetes mellitus | Reabsorption | Sodium | Physiology | Diabetes | Diabetes mellitus (non-insulin dependent)
Journal Article
Circulation, ISSN 0009-7322, 02/2014, Volume 129, Issue 5, pp. 587 - 597
Journal Article
Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 01/2010, Volume 5, Issue 1, pp. 133 - 141
Journal Article
American Journal of Physiology - Endocrinology and Metabolism, ISSN 0193-1849, 01/2013, Volume 304, Issue 2, pp. E117 - E130
Journal Article
American Journal of Physiology - Regulatory Integrative and Comparative Physiology, ISSN 0363-6119, 01/2012, Volume 302, Issue 1, pp. R75 - R83
Journal Article
Journal Article
Molecular Pharmacology, ISSN 0026-895X, 09/2018, Volume 94, Issue 3, pp. 953 - 962
Journal Article
Journal Article